English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Flinders University, Australia
Share :
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
4 Dec 2008
Views:
14904
Rating:
Save
Rate video
Dr. Christos Karapetis
Gene marker indicates doubling of survival time in cetuximab-treated CRC
Categories:
Colorectal & gastro
Diagnostics
Related Videos
New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr Jill Corre - IUCT Oncopole, Toulouse, France
29 Oct 2024
Post-diagnosis diet, nutrition and cancer prognosis
Dr Doris Chan - Imperial College London, London, UK
24 Oct 2024
WCI's role in the prevention of tobacco related cancer among Beedi rolling...
Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India
23 Oct 2024
Alternative livelihood training programme for rural women who are employed in...
Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India
23 Oct 2024
Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges
Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria
19 Jan 2024
Colorectal cancer risk factors in Nigeria
Prof Olusegun Alatise - Obafemi Awolowo University, Ife, Nigeria
19 Jan 2024
Latest treatments in oesophageal cancer
Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA
5 Apr 2023
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates...
Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA
25 Jan 2023
More from
e
cancer